Literature DB >> 20634142

TLR signaling and effector functions are intact in XLA neutrophils.

Thomas U Marron1, Kaileen Rohr, Monica Martinez-Gallo, Joyce Yu, Charlotte Cunningham-Rundles.   

Abstract

Toll-like receptors (TLRs) are essential components of the innate immune system, and their ligands are important activators of neutrophils. Bruton's tyrosine kinase (Btk) has been reported to mediate signaling through toll-like receptors (TLRs) in many cell types, however, the role of Btk in TLR activation of neutrophils remains unclear. Impaired TLR-induced neutrophil function was found in mice with loss of Btk and in humans with TLR-signaling defects, but the integrity of TLR pathways in X-linked agammaglobulinemia (XLA) neutrophils has not been assessed. In this study LPS (TLR4) or an imidazoquinoline compound (TLR7/8) activated XLA neutrophil shedding of surface CD62L, and phosphorylated MAP kinases p38, JNK and ERK. TLR activation also induced normal respiratory burst and retarded apoptosis for XLA neutrophils, comparable to normal controls. These data demonstrate that the loss of Btk in XLA neutrophils does not impair functional responses to TLR signals.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634142      PMCID: PMC2941555          DOI: 10.1016/j.clim.2010.06.011

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  42 in total

1.  Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.

Authors:  Rebeca Pérez de Diego; Eduardo López-Granados; Maite Pozo; Cristina Rodríguez; Prado Sabina; Antonio Ferreira; Gumersindo Fontan; Maria Cruz García-Rodríguez; Susana Alemany
Journal:  J Allergy Clin Immunol       Date:  2006-03-31       Impact factor: 10.793

2.  The health status and quality of life of adults with X-linked agammaglobulinemia.

Authors:  Vanessa Howard; Jeffrey M Greene; Savita Pahwa; Jerry A Winkelstein; John M Boyle; Mehmet Kocak; Mary Ellen Conley
Journal:  Clin Immunol       Date:  2005-12-22       Impact factor: 3.969

3.  Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages.

Authors:  M Liljeroos; R Vuolteenaho; S Morath; T Hartung; M Hallman; M Ojaniemi
Journal:  Cell Signal       Date:  2006-08-30       Impact factor: 4.315

4.  Bruton's tyrosine kinase is required for TLR-induced IL-10 production.

Authors:  Nathan W Schmidt; Vivian T Thieu; Brandon A Mann; Ayele-Nati N Ahyi; Mark H Kaplan
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

5.  X-linked agammaglobulinemia: report on a United States registry of 201 patients.

Authors:  Jerry A Winkelstein; Mary C Marino; Howard M Lederman; Stacie M Jones; Kathleen Sullivan; A Wesley Burks; Mary Ellen Conley; Charlotte Cunningham-Rundles; Hans D Ochs
Journal:  Medicine (Baltimore)       Date:  2006-07       Impact factor: 1.889

6.  Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia.

Authors:  Klára Sochorová; Rudolf Horváth; Daniela Rozková; Jirí Litzman; Jirina Bartunková; Anna Sedivá; Radek Spísek
Journal:  Blood       Date:  2006-11-07       Impact factor: 22.113

7.  Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases.

Authors:  Kazuki Aomatsu; Takayuki Kato; Hisakazu Fujita; Fumihiko Hato; Nobuhide Oshitani; Noriko Kamata; Tomohiko Tamura; Tetsuo Arakawa; Seiichi Kitagawa
Journal:  Immunology       Date:  2007-07-28       Impact factor: 7.397

8.  Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production.

Authors:  Nicole J Horwood; Theresa H Page; John P McDaid; Christine D Palmer; Jamie Campbell; Tara Mahon; Fionula M Brennan; David Webster; Brian M J Foxwell
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

9.  Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase.

Authors:  Sarah L Doyle; Caroline A Jefferies; Con Feighery; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2007-10-11       Impact factor: 5.157

10.  A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.

Authors:  Tae Whan Kim; Kirk Staschke; Katarzyna Bulek; Jianhong Yao; Kristi Peters; Keun-Hee Oh; Yvonne Vandenburg; Hui Xiao; Wen Qian; Tom Hamilton; Booki Min; Ganes Sen; Raymond Gilmour; Xiaoxia Li
Journal:  J Exp Med       Date:  2007-04-30       Impact factor: 14.307

View more
  17 in total

Review 1.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

2.  TLR-induced activation of Btk -- role for endosomal MHC class II molecules revealed.

Authors:  Joan Ní Gabhann; Caroline A Jefferies
Journal:  Cell Res       Date:  2011-05-24       Impact factor: 25.617

3.  The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils.

Authors:  Fumiko Honda; Hirotsugu Kano; Hirokazu Kanegane; Shigeaki Nonoyama; Eun-Sung Kim; Sang-Kyou Lee; Masatoshi Takagi; Shuki Mizutani; Tomohiro Morio
Journal:  Nat Immunol       Date:  2012-02-26       Impact factor: 25.606

4.  Toll-like receptors are potential therapeutic targets in rheumatoid arthritis.

Authors:  Siamak Sandoghchian Shotorbani; Zhao-Liang Su; Hua-Xi Xu
Journal:  World J Biol Chem       Date:  2011-07-26

5.  Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.

Authors:  Thomas U Marron; Monica Martinez-Gallo; Joyce E Yu; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2011-11-16       Impact factor: 10.793

Review 6.  Autoimmunity in Primary Immunodeficiencies (PID).

Authors:  Grace T Padron; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

7.  The effects of Bruton tyrosine kinase inhibition on chemotaxis and superoxide generation in human neutrophils.

Authors:  Arnon Broides; Nurit Hadad; Jacov Levy; Rachel Levy
Journal:  J Clin Immunol       Date:  2014-04-26       Impact factor: 8.317

8.  Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex-Mediated Inflammatory Arthritis.

Authors:  Lindsay E Nyhoff; Bridgette L Barron; Elizabeth M Johnson; Rachel H Bonami; Damian Maseda; Benjamin A Fensterheim; Wei Han; Timothy S Blackwell; Leslie J Crofford; Peggy L Kendall
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

Review 9.  Toll-like receptor function in primary B cell defects.

Authors:  Thomas U Marron; Joyce E Yu; Charlotte Cunningham-Rundles
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

10.  Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies.

Authors:  Roshini S Abraham
Journal:  Clin Mol Allergy       Date:  2011-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.